Exelixis
EXEL
#1822
Rank
โ‚ฌ10.00 B
Marketcap
37,33ย โ‚ฌ
Share price
-0.50%
Change (1 day)
3.07%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚ฌ0.57 Billion

According to Exelixis's latest financial reports the company's total liabilities are โ‚ฌ0.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exelixis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ0.58 B-13.98%
2024-12-31โ‚ฌ0.67 B10.15%
2023-12-31โ‚ฌ0.61 B12.91%
2022-12-31โ‚ฌ0.54 B51.76%
2021-12-31โ‚ฌ0.35 B70.61%
2020-12-31โ‚ฌ0.20 B17.77%
2019-12-31โ‚ฌ0.17 B51.25%
2018-12-31โ‚ฌ0.11 B-61.81%
2017-12-31โ‚ฌ0.30 B-35.89%
2016-12-31โ‚ฌ0.48 B11.26%
2015-12-31โ‚ฌ0.43 B20.13%
2014-12-31โ‚ฌ0.36 B13.82%
2013-12-31โ‚ฌ0.31 B-1.42%
2012-12-31โ‚ฌ0.32 B37.77%
2011-12-31โ‚ฌ0.23 B-47.38%
2010-12-31โ‚ฌ0.44 B25.12%
2009-12-31โ‚ฌ0.35 B8.07%
2008-12-31โ‚ฌ0.32 B46.42%
2007-12-31โ‚ฌ0.22 B-3.17%
2006-12-31โ‚ฌ0.23 B-0.64%
2005-12-31โ‚ฌ0.23 B31.04%
2004-12-31โ‚ฌ0.17 B13.78%
2003-12-31โ‚ฌ0.15 B-0.12%
2002-12-31โ‚ฌ0.15 B26.03%
2001-12-31โ‚ฌ0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ99.69 B 17,125.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ97.97 B 16,827.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ68.22 B 11,687.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ55.94 B 9,565.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ65.77 B 11,265.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ60.60 B 10,371.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ51.92 B 8,871.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
โ‚ฌ35.86 M-93.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚ฌ61.33 M-89.40%๐Ÿ‡บ๐Ÿ‡ธ USA